Expansion of all the diabetes treatments’ insurance benefits, solving doctors’ dilemmas
Although DPP-4 inhibitors, SGLT-2 inhibitors, basal insulin and GLP-1 analogues have different mechanisms, they are all used to cure diabetes.
These treatments, however, are practically included in the insurance benefit expansion. The insurance benefit standard of DPP-4 inhibitors was eased prev...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
